Population
Patients with cancer (including cervical, colon, breast, leukemia, and ovarian cancer)
Design
Review
Authors
Loading...
May support Eag1 as prognostic marker in select cancers; leaves open validation as diagnostic or therapeutic target.
Eag1 channels show potential as early diagnostic and prognostic biomarkers, as well as therapeutic targets, across multiple cancer types.
Rodríguez-Rasgado et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: